Coeptis Therapeutics Holdings, Inc. filed a Form D with the Securities and Exchange Commission on 2025-08-07.
Coeptis Therapeutics Holdings, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 7, 2025. The filing reports $4M sold. Its industry group is Pharmaceuticals. It names David Mehalick (Executive Officer, Director), Daniel Yerace (Director), Brian Cogley (Executive Officer) (SEC Form D, August 7, 2025).
Is this your company?
Sell to companies like Coeptis Therapeutics Holdings, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-07 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Coeptis Therapeutics Holdings, Inc.
Free to see. No signup.
More on the people and the money behind Coeptis Therapeutics Holdings, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Pennsylvania, filed within 90 days of this one, largest first.
Get an email when Coeptis Therapeutics Holdings, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Coeptis Therapeutics Holdings, Inc. raises, hires or launches. No email unless you switch it on.
Watch Coeptis Therapeutics Holdings, Inc. →Get the full cited report on Coeptis Therapeutics Holdings, Inc.
What the filing shows about Coeptis Therapeutics Holdings, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Coeptis Therapeutics Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Coeptis Therapeutics Holdings, Inc.'s address as 105 Bradford Road, Suite 420, Wexford, PA 15090.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Coeptis Therapeutics Holdings, Inc. See pricing
Coeptis Therapeutics Holdings, Inc. is a registered filer with the SEC (CIK 1759186) and has filed since 2023-11-03. 3 filings are on record, the latest on 2025-08-07.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Coeptis Therapeutics Holdings, Inc.'s Form D of 2025-08-07 names David Mehalick, Daniel Yerace, Brian Cogley and 5 more as its officers, directors or promoters.
Its new offerings report $10.30M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
David Mehalick is named as Executive Officer and Director on the Form D that Coeptis Therapeutics Holdings, Inc. filed with the SEC on 7 August 2025, one of 8 people that filing names.
Daniel Yerace is named as Director on the Form D that Coeptis Therapeutics Holdings, Inc. filed with the SEC on 7 August 2025, one of 8 people that filing names.
Brian Cogley is named as Executive Officer on the Form D that Coeptis Therapeutics Holdings, Inc. filed with the SEC on 7 August 2025, one of 8 people that filing names.
Christopher Calise is named as Director on the Form D that Coeptis Therapeutics Holdings, Inc. filed with the SEC on 7 August 2025, one of 8 people that filing names.
Christopher Cochran is named as Director on the Form D that Coeptis Therapeutics Holdings, Inc. filed with the SEC on 7 August 2025, one of 8 people that filing names.
Tara DeSilva is named as Director on the Form D that Coeptis Therapeutics Holdings, Inc. filed with the SEC on 7 August 2025, one of 8 people that filing names.
Philippe Deschamps is named as Director on the Form D that Coeptis Therapeutics Holdings, Inc. filed with the SEC on 7 August 2025, one of 8 people that filing names.
Gene Salkind is named as Director on the Form D that Coeptis Therapeutics Holdings, Inc. filed with the SEC on 7 August 2025, one of 8 people that filing names.
8 people named on the filing — 2 holding an executive role and 6 as directors only.
Named as of the 2025-08-07 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Coeptis Therapeutics Holdings, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Coeptis Therapeutics Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Coeptis Therapeutics Holdings, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Coeptis Therapeutics Holdings, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Coeptis Therapeutics Holdings, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Coeptis Therapeutics Holdings, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Pittsburgh
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/coeptis-therapeutics-holdings-inc-form-d-25000001